Research Update for Triple Negative MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

preview_player
Показать описание
Filipa Lynce, MD, and Sara Tolaney, MD, MPH, discuss advances in research and treatment for patients with triple negative metastatic breast cancer.
  1. Dana-Farber Cancer Institute
  2. Dana-Farber Cancer Institute
  3. DFCI
  4. Dana-Farber
  5. cancer
  6. Metastatic Breast Cancer
Рекомендации по теме
Research Update for 1:01:54

Research Update for Triple Negative MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

Research Update for 1:07:16

Research Update for Triple Negative MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Research Update for 1:01:47

Research Update for Triple Negative MBC | 2023-2024 EMBRACE MBC Virtual Forum Series

Triple Negative MBC 1:00:19

Triple Negative MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum Series

2020 EMBRACE Metastatic 1:00:59

2020 EMBRACE Metastatic Breast Cancer Virtual Forum Series | Research Update for Triple-Negative MBC

Medical update: Metastatic 0:43:03

Medical update: Metastatic triple-negative breast cancer

Study of Carboplatin 0:07:40

Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer

ASCO Breast Cancer 0:42:02

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew Sedona

Inhibition of Resistant 0:09:23

Inhibition of Resistant Triple-negative Breast Cancer Cells | Oncotarget

The challenges of 0:02:21

The challenges of treating early-stage TNBC

Oncotarget: CRISPR Used 0:00:59

Oncotarget: CRISPR Used in Triple Negative Breast Cancer Research

Study of SACI-IO 0:05:42

Study of SACI-IO for Triple Negative Metastatic Breast Cancer

Metastatic Triple-Negative Breast 0:28:25

Metastatic Triple-Negative Breast Cancer Ongoing Trials

Metastatic Breast Cancer: 1:04:51

Metastatic Breast Cancer: A Medical and Research Update

ESMO 2020 Expert 0:07:36

ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC

Encouraging developments in 0:01:39

Encouraging developments in triple negative breast cancer immunotherapy

Neoadjuvant and adjuvant 0:02:52

Neoadjuvant and adjuvant therapy in triple negative breast cancer

Moffitt Medical Minute: 0:01:26

Moffitt Medical Minute: Triple Negative Breast Cancer Treatment

Bench To Bedside 0:31:21

Bench To Bedside S8E13: The Future of Triple-Negative Breast Cancer Treatment

New Treatment Shows 0:02:21

New Treatment Shows Promise For Triple-Negative Breast Cancer Patients

Immunotherapy for Triple-Negative 0:08:32

Immunotherapy for Triple-Negative Breast Cancer

Brooke Emerling, Ph.D., 0:00:58

Brooke Emerling, Ph.D., Sanford Burnham Prebys - Triple Negative Breast Cancer (TNBC)

Triple-Negative Breast Cancer 0:02:37

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening - Mayo Clinic

Future directions in 0:01:04

Future directions in triple-negative breast cancer research

Комментарии
Автор

I’m a white 64 year old, triple neg, negative BRCA 1-2, and healthy with no medical issues. 🤷🏻‍♀️
Mastectomy 10 days ago and no cancer in lymph’s. No further treatment needed. A visit to my Oncologist every 3 months.

CkCmilliemoo